Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 April 2004, Vol. 103, No. 8, pp. 2866-2867.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touw, I. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Touw, I. P.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

A casein kinase making its case in granulopoiesis

The casein kinase I (CKI) serine/threonine kinases are highly conserved among eukaryotes and have been implicated in a variety of processes, ranging from the regulation of DNA repair and cell cycle progression in yeast to the control of circadian rhythm and embryogenesis in mammals. The latter activities are attributed mainly to CKI{epsilon}, one of the 7 mammalian CKI isoforms. CKI{epsilon} has been shown to act as a positive regulator in the canonical Wnt signaling pathway by stabilizing {beta}-catenin.1 The recent discovery that self-renewal of hematopoietic stem cells is controlled by Wnt positions CKI{epsilon} in a regulatory network controlling early cell fate decisions in hematopoietic development.2,3

In this issue of Blood, Okamura and colleagues (page 2997) provide evidence for a more extended role for CKI{epsilon} in hematopoietic differentiation. Using the mouse 32D cell system, they show that CKI{epsilon} levels remain high when cells are kept immature in the presence of interleukin-3, resulting in increased {beta}-catenin stabilization. On the other hand, upon granulocyte colony-stimulating factor (G-CSF)–induced differentiation of the 32D cells, expression of CKI{epsilon} is down-regulated. When CKI{epsilon} is constitutively expressed from a retroviral vector in these cells, neutrophilic differentiation is largely prohibited. Conversely, a kinase-dead form of CKI{epsilon} accelerates G-CSF–induced differentiation. These results suggest that CKI{epsilon} antagonizes G-CSF–controlled neutrophil development in the 32D system. While the contribution of CKI{epsilon} in granulopoiesis under conditions that are more physiologic remains to be established, it is intriguing to speculate how the negative effects of CKI{epsilon} on granulocytic differentiation are mediated.Go


One mechanism by which G-CSF controls granulopoiesis is through activation of the signal transducer and activator of transcription 3 (STAT3). Although overexpression of dominant-negative forms of STAT3 prohibits G-CSF–induced differentiation in myeloid cell line models,4,5 studies in a conditional STAT3 knockout model show that STAT3 is not essential for neutrophil development per se, but contributes to the growth arrest that precedes differentiation.6 Typically, mice lacking STAT3 in their hematopoietic cell compartment display hyperproliferative responses to G-CSF treatment, leading to a significantly larger increase in peripheral neutrophil levels compared with wild-type controls. The gene encoding the suppressor of cytokine signaling protein 3 (SOCS3) was suggested to be the STAT3 target gene predominantly responsible for the phenotype of these mice,6 a conclusion that gains strong support from a recent study in a conditional SOCS3 knockout model, in which G-CSF responses are remarkably similar to those of the STAT3-deficient mice.7

Okamura and colleagues show that overexpression of CKI{epsilon} stabilizes SOCS3 by inhibiting its proteasomal degradation. They suggest that the prolonged action of SOCS3 reduces G-CSF–induced activation of STAT3, which in turn leads to the attenuation of differentiation in the 32D model. At first glance this hypothesis cannot be reconciled with the largely overlapping pheno types of STAT3- and SOCS3-deficient mice. However, the regulatory functions of SOCS proteins may be more subtle than predicted by gene knockout or ectopic overexpression models because their activity depends on a variety of factors, including expression levels in a given cell type. Okamura and colleagues observed that, in contrast to STAT3, activation of STAT5 was not affected by CKI{epsilon}. Predictably, this will result in an increased ratio of STAT5 to STAT3 activation, a state that has been associated with increased proliferation and reduced differentiation of myeloid progenitor cells. The authors speculate that the exclusive effect of CKI{epsilon} on STAT3 activation may be related to its higher sensitivity to SOCS3-mediated Jak kinase inhibition compared with STAT5, but another explanation may arise from their intriguing observation that SOCS3 forms a complex with STAT3. Through such binding, SOCS3 (stabilized by CKI{epsilon}) could inhibit transcriptional activity of STAT3 during immature stages of myeloid development, for instance by attenuating translocation of activated STAT3 complexes to the nucleus.

Although a number of questions remain open, the work of Okamura and colleagues provides exciting evidence for a role of CKI{epsilon} in controlling hematopoietic cell fate, particularly in the neutrophilic lineage. It will now be relevant to study the contribution of CKI{epsilon} in other hematopoietic lineages and to investigate its involvement in various hematologic disorders such as myelodysplasia and acute myeloid leukemia.

--- Ivo P. Touw
Erasmus University Medical Center

References

  1. Peters JM, McKay RM, McKay JP, Graff JM. Casein kinase I transduces Wnt signals. Nature. 1999;401: 345-350.[CrossRef][Medline] [Order article via Infotrieve]

  2. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003;423: 409-414.[CrossRef][Medline] [Order article via Infotrieve]

  3. Willert K, Brown JD, Danenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature. 2003;423: 448-452.[CrossRef][Medline] [Order article via Infotrieve]

  4. Shimozaki K, Nakajima K, Hirano T, Nagata S. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J Biol Chem. 1997;272: 25184-25189.[Abstract/Free Full Text]

  5. de Koning JP, Soede-Bobok AA, Ward AC, et al. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene. 2000;19: 3290-3298.[CrossRef][Medline] [Order article via Infotrieve]

  6. Lee CK, Raz R, Gimeno R, et al. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity. 2002;17: 63-72.[CrossRef][Medline] [Order article via Infotrieve]

  7. Kimura A, Kinjyo I, Matsumura Y, et al. SOCS3 is a physiological negative regulator for granulopoiesis and G-CSF receptor signaling. J Biol Chem. 2004;279: 6905-6910.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Involvement of casein kinase I{epsilon} in cytokine-induced granulocytic differentiation
Atsuo Okamura, Nobuko Iwata, Aki Nagata, Akira Tamekane, Manabu Shimoyama, Hiroshi Gomyo, Kimikazu Yakushijin, Norinaga Urahama, Miyuki Hamaguchi, Chie Fukui, Kazuo Chihara, Mitsuhiro Ito, and Toshimitsu Matsui
Blood 2004 103: 2997-3004. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touw, I. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Touw, I. P.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020